Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury

Yoko Ito, Tomoko Betsuyaku, Katsura Nagai, Yasuyuki Nasuhara, Masaharu Nishimura

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

Original languageEnglish
Pages (from-to)315-323
Number of pages9
JournalExperimental Gerontology
Volume40
Issue number4
DOIs
Publication statusPublished - 2005 Apr
Externally publishedYes

Fingerprint

Lung Injury
Vascular Endothelial Growth Factor A
Lipopolysaccharides
Lung
Vascular Endothelial Growth Factor Receptor-3
Vascular Endothelial Growth Factor B
Vascular Endothelial Growth Factor D
Animals
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor Receptor
Survival
Wounds and Injuries
Endothelial cells
Pneumonia
Protein Isoforms
Down-Regulation
Endothelial Cells
Polymerase Chain Reaction
Mortality

Keywords

  • Acute lung injury
  • Aging
  • LPS
  • VEGF
  • VEGF receptors
  • VEGF-A isoforms

ASJC Scopus subject areas

  • Ageing
  • Medicine(all)

Cite this

Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. / Ito, Yoko; Betsuyaku, Tomoko; Nagai, Katsura; Nasuhara, Yasuyuki; Nishimura, Masaharu.

In: Experimental Gerontology, Vol. 40, No. 4, 04.2005, p. 315-323.

Research output: Contribution to journalArticle

Ito, Yoko ; Betsuyaku, Tomoko ; Nagai, Katsura ; Nasuhara, Yasuyuki ; Nishimura, Masaharu. / Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. In: Experimental Gerontology. 2005 ; Vol. 40, No. 4. pp. 315-323.
@article{0f2ff7b23db746beba5043a7cef4b52b,
title = "Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury",
abstract = "Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.",
keywords = "Acute lung injury, Aging, LPS, VEGF, VEGF receptors, VEGF-A isoforms",
author = "Yoko Ito and Tomoko Betsuyaku and Katsura Nagai and Yasuyuki Nasuhara and Masaharu Nishimura",
year = "2005",
month = "4",
doi = "10.1016/j.exger.2005.01.009",
language = "English",
volume = "40",
pages = "315--323",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury

AU - Ito, Yoko

AU - Betsuyaku, Tomoko

AU - Nagai, Katsura

AU - Nasuhara, Yasuyuki

AU - Nishimura, Masaharu

PY - 2005/4

Y1 - 2005/4

N2 - Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

AB - Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

KW - Acute lung injury

KW - Aging

KW - LPS

KW - VEGF

KW - VEGF receptors

KW - VEGF-A isoforms

UR - http://www.scopus.com/inward/record.url?scp=16844368855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844368855&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2005.01.009

DO - 10.1016/j.exger.2005.01.009

M3 - Article

VL - 40

SP - 315

EP - 323

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 4

ER -